Bank of America’s Verve Therapeutics VERV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.46M | Sell |
485,803
-1,147,073
| -70% | -$12.9M | ﹤0.01% | 3236 |
|
|
2025
Q1 | $7.46M | Buy |
1,632,876
+1,085,205
| +198% | +$4.96M | ﹤0.01% | 2917 |
|
|
2024
Q4 | $3.09M | Sell |
547,671
-228,551
| -29% | -$1.29M | ﹤0.01% | 3429 |
|
|
2024
Q3 | $3.76M | Buy |
776,222
+303,206
| +64% | +$1.47M | ﹤0.01% | 3405 |
|
|
2024
Q2 | $2.31M | Buy |
473,016
+99,792
| +27% | +$487K | ﹤0.01% | 3691 |
|
|
2024
Q1 | $4.96M | Buy |
373,224
+135,351
| +57% | +$1.8M | ﹤0.01% | 3062 |
|
|
2023
Q4 | $3.32M | Sell |
237,873
-76,899
| -24% | -$1.07M | ﹤0.01% | 3242 |
|
|
2023
Q3 | $4.17M | Buy |
314,772
+141,905
| +82% | +$1.88M | ﹤0.01% | 2975 |
|
|
2023
Q2 | $3.24M | Sell |
172,867
-211,839
| -55% | -$3.97M | ﹤0.01% | 3196 |
|
|
2023
Q1 | $5.55M | Sell |
384,706
-20,687
| -5% | -$298K | ﹤0.01% | 2936 |
|
|
2022
Q4 | $7.84M | Buy |
405,393
+261,198
| +181% | +$5.05M | ﹤0.01% | 2479 |
|
|
2022
Q3 | $4.95M | Buy |
144,195
+125,406
| +667% | +$4.31M | ﹤0.01% | 2848 |
|
|
2022
Q2 | $287K | Sell |
18,789
-192,605
| -91% | -$2.94M | ﹤0.01% | 5107 |
|
|
2022
Q1 | $4.82M | Buy |
211,394
+160,544
| +316% | +$3.66M | ﹤0.01% | 3182 |
|
|
2021
Q4 | $1.88M | Buy |
50,850
+48,594
| +2,154% | +$1.79M | ﹤0.01% | 3965 |
|
|
2021
Q3 | $106K | Buy |
2,256
+1,884
| +506% | +$88.5K | ﹤0.01% | 5827 |
|
|
2021
Q2 | $22K | Buy |
+372
| New | +$22K | ﹤0.01% | 6290 |
|